5-(4-piperidyl)isoxazol-3-ol has been researched along with valine in 1 studies
Studies (5-(4-piperidyl)isoxazol-3-ol) | Trials (5-(4-piperidyl)isoxazol-3-ol) | Recent Studies (post-2010) (5-(4-piperidyl)isoxazol-3-ol) | Studies (valine) | Trials (valine) | Recent Studies (post-2010) (valine) |
---|---|---|---|---|---|
21 | 0 | 4 | 15,465 | 1,176 | 3,932 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akaike, N; Murai, Y; Nielsen, M; Noguchi, K; Westh-Hansen, SE; Witt, MR | 1 |
1 other study(ies) available for 5-(4-piperidyl)isoxazol-3-ol and valine
Article | Year |
---|---|
Effects of 5-(4-piperidyl) isoxazol-3-ol (4-PIOL), a GABA(A) receptor partial agonist, on recombinant human GABA(A) receptors.
Topics: Animals; Cell Line; GABA Agonists; gamma-Aminobutyric Acid; Humans; Isoxazoles; Kinetics; Macromolecular Substances; Membrane Potentials; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Piperidines; Receptors, GABA-A; Recombinant Proteins; Spodoptera; Transfection; Valine | 1997 |